CoChat

Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial

Open access

The DOI matches its Crossref record; 43 of the 47 references it cites were found in a registry or an index.

Abstract

Background: Hashimoto disease is a chronic autoimmune thyroiditis. Despite adequate hormone substitution, some patients have persistent symptoms that may be the result of immunologic pathophysiology. Objective: To determine whether thyroidectomy improves symptoms in patients with Hashimoto thyroiditis who still have symptoms despite having normal thyroid gland function while receiving medical therapy. Design: Randomized trial. (ClinicalTrials.gov: NCT02319538). Setting: Secondary care hospital in Norway. Patients: 150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum antithyroid peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL. Intervention: Total thyroidectomy or medical management with hormone substitution to secure euthyroid status in both groups. Measurements: The primary outcome was general health score on the Short Form-36 Health Survey (SF-36) at 18 months. Secondary outcomes were adverse effects of surgery, the other 7 SF-36 subscores, fatigue questionnaire scores, and serum anti-TPO antibody titers at 6, 12, and 18 months. Results: During follow-up, only the surgical group demonstrated improvement: Mean general health score increased from 38 to 64 points, for a between-group difference of 29 points (95% CI, 22 to 35 points) at 18 months. Fatigue score decreased from 23 to 14 points, for a between-group difference of 9.3 points (CI, 7.4 to 11.2 points). Chronic fatigue frequency decreased from 82% to 35%, for a between-group difference of 39 percentage points (CI, 23 to 53 percentage points). Median serum anti-TPO antibody titers decreased from 2232 to 152 IU/mL, for a between-group difference of 1148 IU/mL (CI, 1080 to 1304 IU/mL). In multivariable regression analyses, the adjusted treatment effects remained similar to the unadjusted effects. Limitation: Results are applicable only to a subgroup of patients with Hashimoto disease, and follow-up was limited to 18 months. Conclusion: Total thyroidectomy improved health-related quality of life and fatigue, whereas medical therapy did not. This improvement, along with concomitant elimination of serum anti-TPO antibodies, may elucidate disease mechanisms. Primary Funding Source: Telemark Hospital.

Overview

Integrity signals

Registry

Crossref · 10.7326/m18-0284

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 2

  1. Hashimoto H, 1912, Arch Klin Chir, 219
  2. Weetman AP, 1982, Clin Exp Immunol, 48, 196

Cited by

See all 99

Metadata

Authors
Guldvog, I., Reitsma, L. C., Johnsen, L., Lauzike, A., Gibbs, C., Carlsen, E., Lende, T. H., Narvestad, J. K., Omdal, R., Kvaløy, J. T., Hoff, G., Bernklev, T., & Søiland, H.
Affiliations
  • Telemark Hospital (NO)
  • Stavanger University Hospital (NO)
  • University of Oslo (NO)
Venue
Annals of Internal Medicine
Published
2019-04-02
Volume
170
Issue
7
Pages
453-464
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2922355726
Cited by
99
References
47
Citations by year
2026: 8 · 2025: 18 · 2024: 15 · 2023: 10 · 2022: 11 · 2021: 18 · 2020: 12 · 2019: 6
FWCI
11.21
Type
journal article
Language
en
Open access
Licence
  • other-oa
  • www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • Annals of Internal Medicine
Topics
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
Keywords
Hashimoto's thyroiditis, total thyroidectomy, euthyroid patients, persistent symptoms, thyroid peroxidase antibodies, health-related quality of life, fatigue, hormone replacement therapy, autoimmune thyroiditis, surgical versus medical management, SF-36 Health Survey, postoperative adverse reactions, disease mechanisms, chronic fatigue syndrome, thyroid autoimmunity
MeSH terms
Patient Reported Outcome Measures, Adolescent, Adult, Aged, Antibodies, Drug Therapy, Combination, Fatigue, Female, Follow-Up Studies, Humans, Iodide Peroxidase, Male, Middle Aged, Postoperative Complications, Quality of Life, Thyroid Gland, Thyroidectomy, Thyroxine, Triiodothyronine, Hormone Replacement Therapy, Hashimoto Disease, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.